Company
Every investor coverage indicates participated in a round Lixa raised.
Investors whose own portfolio pages list Lixa, even though we haven't found any coverage of the round yet.
| Investor | Listed on |
|---|---|
| Melt Ventures | its portfolio page ↗ |
Companies Lixa acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Maud Eijkenboom | CEO | Startup News (WA) |
Stories naming Lixa. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
A biomedical startup launched publicly at an entrepreneurship event, with its co-founder and chief executive describing antibiofilm technology targeting antimicrobial resistance, alongside mention of a prior grant and a raise.